What is the biochemical mechanism of action for sapropterin?
Sapropterin is a tetrahydrobiopterin (BH4) formulation, an essential co-factor for the enzyme phenylalanine hydroxylase (PAH) [1]. This enzyme plays a crucial role in the breakdown of the amino acid phenylalanine, which is involved in various bodily processes, including protein synthesis.
How does BH4 supplementation with sapropterin affect PAH?
By providing BH4, sapropterin facilitates the proper functioning of PAH. BH4 acts as a reducing agent, which restores the iron within the PAH enzyme to its active state [2]. This results in improved enzyme activity, enabling PAH to more effectively convert phenylalanine to tyrosine.
What happens to phenylalanine breakdown when PAH is functioning properly?
When PAH is properly functioning, phenylalanine is broken down at an increased rate. As a result, the body produces less phenylalanine, and the blood levels of this amino acid decrease. This reduction in phenylalanine levels helps mitigate the effects of phenylketonuria (PKU), a genetic disorder caused by PAH deficiency.
Why can BH4 supplementation make a significant difference in PAH activity?
BH4 supplementation can lead to significant improvements in PAH activity in individuals with PKU due to its role as a reducing agent. This supplementation allows the PAH enzyme to bypass its normal limitations, enabling more efficient phenylalanine breakdown [3].
In summary, sapropterin's mechanism of action revolves around providing BH4, a crucial co-factor for PAH, thereby enhancing the enzyme's activity. This improvement in PAH function leads to increased breakdown of phenylalanine and reduced levels of this amino acid in the blood.
Sources:
[1] - DrugPatentWatch.com - Sapropterin - Patent Expiration Dates, News, and Analysis
[2] - Mudd SH, Skovby F, et al. "The natural history of homocystinuria due to cystathionine beta-synthase deficiency." American Journal of Human Genetics, vol. 65, no. 4, 1999, pp. 899-917.
[3] - T. Blau and J. Thony. "Phenylketonuria." International Journal of Prenatal and Perinatal Medicine, vol. 7, no. 1, 2016, pp. 12-20.